Publications:  Prof Richard Ashcroft

Goddard A, Burn W, Regan L, Viner R, Stokes-Lampard H, Mahajan R, Anagnostara E, Hollins S et al.(2018). Open letter to Simon Stevens to ensure that tobacco dependence treatment is provided for every smoker cared for by the NHS, as part of the long term plan. BMJ vol. 363,

CLINCH ML, SHAW S, ASHCROFT R, SWINGLEHURST D(2018). Liminality in Practice: A Case study in Life Sciences Research. BioSocieties

Ashcroft RE(2018). Euthanasia and the nature of suffering in addiction. Addiction vol. 113, (7) 1183-1184.

Cao KX, Booth A, Ourselin S, David AL, Ashcroft R(2018). The legal frameworks that govern fetal surgery in the United Kingdom, European Union, and the United States. Prenat Diagn vol. 38, (7) 475-481.

Ashcroft RE(2018). Law and the perils of philosophical grafts. JOURNAL OF MEDICAL ETHICS vol. 44, (1) 72-72.

Osman M, Lin Y, Ashcroft R(2017). Nudging: A Lesson in the Theatrics of Choice. Basic and Applied Social Psychology1-6.

Ashcroft RE(2017). Confidentiality and Its Discontents: Dilemmas of Privacy in Psychotherapy. PSYCHOANALYSIS AND HISTORY vol. 19, (3) 426-428.

Lin Y, Osman M, Ashcroft R(2017). Nudge: Concept, Effectiveness, and Ethics. Basic and Applied Social Psychology vol. 39, (6) 293-306.

Ashcroft R(2017). Being and Owning: The Body, Bodily Material, and the Law. MODERN LAW REVIEW vol. 80, (6) 1186-1189.

Ashcroft RE(2017). Multiple Autisms: Spectrums of Advocacy and Genomic Science. Ann Sci vol. 74, (3) 248-250.

Estcourt CS, Gibbs J, Sutcliffe LJ, Gkatzidou V, Tickle L, Hone K, Aicken C, Lowndes CM et al.(2017). The eSexual Health Clinic system for management, prevention, and control of sexually transmitted infections: exploratory studies in people testing for Chlamydia trachomatis. Lancet Public Health vol. 2, (4) e182-e190.

Ashcroft RE(2017). Incentives, Nudges and the Burden of Proof in Ethical Argument. J Med Ethics vol. 43, (3)

Gibbs J, Gkatzidou V, Tickle L, Manning SR, Tilakkumar T, Hone K, Ashcroft RE, Sonnenberg P et al.(2016). 'Can you recommend any good STI apps?' A review of content, accuracy and comprehensiveness of current mobile medical applications for STIs and related genital infections. Sex Transm Infect vol. 93, (4) 234-235.

Nicholls SG, Newson AJ, Ashcroft RE(2016). The need for ethics as well as evidence in evidence-based medicine. J Clin Epidemiol vol. 77, 7-10.

Ashcroft R(2016). Bioethics in historical perspective. NEW GENETICS AND SOCIETY vol. 37, (1) 88-89.

Gibbs J, Sutcliffe LJ, Gkatzidou V, Hone K, Ashcroft RE, Harding-Esch EM, Lowndes CM, Sadiq ST et al.(2016). The eClinical Care Pathway Framework: a novel structure for creation of online complex clinical care pathways and its application in the management of sexually transmitted infections. BMC Medical Informatics and Decision Making vol. 16, (1)

Rodogno R, Krause-Jensen K, Ashcroft RE(2016). ‘Autism and the good life’: a new approach to the study of well-being. Journal of Medical Ethics vol. 42, (6) 401-408.

Sheppard M, Spencer RN, Ashcroft R, David AL(2016). Ethics and social acceptability of a proposed clinical trial using maternal gene therapy to treat severe early-onset fetal growth restriction. Ultrasound in Obstetrics & Gynecology vol. 47, (4) 484-491.

Greenhalgh T, Annandale E, Ashcroft R, Barlow J, Black N, Bleakley A, Boaden R, Braithwaite J et al.(2016). An open letter to The BMJ editors on qualitative research. BMJ vol. 352,

ASHCROFT RE(2016). Ethical Issues in a Trail of Maternal Gene Transfer to Improve Foetal Growth.

Gibbs J, Sutcliffe LJ, Gkatzidou V, Sonnenberg P, Hone K, Ashcroft R, Harding-Esch E, Lowndes C et al. (2015). DEVELOPING AND USING THE ECLINICAL CARE PATHWAY FRAMEWORK: A NOVEL TOOL FOR CREATING ONLINE CLINICAL CARE PATHWAYS AND ITS APPLICATION TO MANAGEMENT OF GENITAL CHLAMYDIA. SEXUALLY TRANSMITTED INFECTIONS. vol. 91, A186-A186.

Gibbs J, Gkatzidou V, Tickle L, Manning SR, Tilakkumar T, Hone K, Ashcroft RE, Sonnenberg P et al. (2015). HOW ACCURATE AND COMPREHENSIVE ARE CURRENTLY AVAILABLE MOBILE MEDICAL APPLICATIONS (APPS) FOR SEXUALLY TRANSMITTED AND GENITAL INFECTIONS: A COMPREHENSIVE REVIEW. SEXUALLY TRANSMITTED INFECTIONS. vol. 91, A186-A187.

Estcourt CS, Gibbs J, Sutcliffe LJ, Gkatzidou V, Tickle L, Hone K, Aicken C, Lowndes C et al. (2015). IS AN AUTOMATED ONLINE CLINICAL CARE PATHWAY FOR PEOPLE WITH GENITAL CHLAMYDIA (CHLAMYDIA-OCCP) WITHIN AN ESEXUAL HEALTH CLINIC FEASIBLE AND ACCEPTABLE? PROOF OF CONCEPT STUDY. SEXUALLY TRANSMITTED INFECTIONS. vol. 91, A55-A55.

Wild V, Zion D, Ashcroft R(2015). Health of Migrants: Approaches from a Public Health Ethics Perspective. PUBLIC HEALTH ETHICS vol. 8, (2) 107-109.

(2015). Does Vascular Endothelial Growth Factor Gene Therapy Safely Improve Outcome in Severe Early-Onset Fetal Growth Restriction? (EVERREST). Hum Gene Ther Clin Dev vol. 26, (2) 82-84.

Leber W, McMullen H, Marlin N, Bremner S, Boomla K, Kerry S, Martineau A, Griffi C et al.(2015). Promotion of rapid testing for HIV in primary care (RHIVA2): A cluster-randomised controlled trial. The Lancet HIV vol. 2, (6) e229-e235.

Leber W, McMullen H, Anderson J, Marlin N, Santos AC, Bremner S, Boomla K, Kerry S et al.(2015). Promotion of rapid testing for HIV in primary care (RHIVA2): a cluster-randomised controlled trial. The Lancet HIV vol. 2, (6) e229-e235.

Ashcroft RE(2015). The ethics of an opt-out default in tobacco treatment. Addiction vol. 110, (3) 389-390.

Sheppard MK, Spencer RN, David AL, Ashcroft R (2014). Evaluation of the ethics and social acceptability of a proposed clinical trial using maternal gene therapy to treat severe early-onset fetal growth restriction in pregnant women. HUMAN GENE THERAPY. vol. 25, A98-A99.

Britton J, Bogdanovica I, Ashcroft R, McNeill A(2014). Electronic cigarettes, smoking and population health. Clin Med (Lond) vol. 14, (4) 334-337.

Gibbs J, Sutcliffe L, Sadig T, Sonnenberg P, Ashcroft R, Gkaczidou V, Hone K, Estcourt C (2014). DEVELOPMENT OF AN AUTOMATED ONLINE CLINICAL CONSULTATION WITH ELECTRONIC ANTIBIOTIC PRESCRIBING FOR THE REMOTE MANAGEMENT OF GENITAL CHLAMYDIA TRACHOMATIS INFECTION WITHIN THE ESTI2 CONSORTIUM. SEXUALLY TRANSMITTED DISEASES. vol. 41, S69-S69.

Gibbs J, Sutcliffe L, Ashcroft RE, Sonnenberg P, Sadiq ST, Estcourt C (2014). DEVELOPMENT OF AN ELECTRONIC PRESCRIBING SYSTEM, LINKING SPECIALIST SEXUAL HEALTH SERVICES AND COMMUNITY PHARMACIES TO SUPPORT AN ONLINE CLINICAL CONSULTATION FOR REMOTE MANAGEMENT OF PEOPLE WITH GENITAL CHLAMYDIA TRACHOMATIS WITHIN THE ESTI2 CONSORTIUM. SEXUALLY TRANSMITTED DISEASES. vol. 41, S38-S38.

Sheppard M, David A, Spencer R, Ashcroft R(2014). PFM.08 Ethics and ethical evaluation of a proposed clinical trial with maternal uterine artery vascular endothelial growth factor gene therapy to treat severe early-onset fetal growth restriction in pregnant women. Arch Dis Child Fetal Neonatal Ed vol. 99 Suppl 1,

Leber W, McMullen H, Marlin N, Bremner S, Santos AC, Terris-Prestholt F, Boomla K, Ashcroft R et al. (2013). Point-of-care HIV testing in primary care and early detection of HIV (RHIVA2): a cluster randomised controlled trial. LANCET. vol. 382, 7-7.

Parke H, Ashcroft R, Brown R, Marteau TM, Seale C(2013). Financial incentives to encourage healthy behaviour: an analysis of U.K. media coverage. Health Expect vol. 16, (3) 292-304.

Ashcroft RE(2013). Doing good by stealth: comments on 'Salvaging the concept of nudge'. JOURNAL OF MEDICAL ETHICS vol. 39, (8) 494-494.

Ashcroft RE(2013). Conflicts of Interest and the Future of Medicine. MEDICAL HISTORY vol. 57, (1) 154-155.

Mein G, Seale C, Rice H, Johal S, Ashcroft RE, Ellison G, Tinker A(2012). Altruism and participation in longitudinal health research? Insights from the Whitehall II Study. SOCIAL SCIENCE & MEDICINE vol. 75, (12) 2345-2352.

Saunders R, Ashcroft RE(2012). Consumer genetics and addiction susceptibility testing-just what the consumer ordered. Addiction vol. 107, (12) 2075-2076.

Mein G, Johal S, Grant RL, Seale C, Ashcroft R, Tinker A(2012). Predictors of two forms of attrition in a longitudinal health study involving ageing participants: An analysis based on the Whitehall II study. BMC MEDICAL RESEARCH METHODOLOGY vol. 12, Article ARTN 164,

Coutelle C, Ashcroft R(2012). Risks, benefits and ethical, legal, and societal considerations for translation of prenatal gene therapy to human application. Methods Mol Biol vol. 891, 371-387.

Sinclair JMA, Burton A, Ashcroft R, Priebe S(2011). Clinician and service user perceptions of implementing contingency management: a focus group study. Drug Alcohol Depend vol. 119, (1-2) 56-63.

Greenhalgh T, Russell J, Ashcroft RE, Parsons W(2011). Why national eHealth programs need dead philosophers: Wittgensteinian reflections on policymakers' reluctance to learn from history. Milbank Q vol. 89, (4) 533-563.

Promberger M, Brown RCH, Ashcroft RE, Marteau TM(2011). Acceptability of financial incentives to improve health outcomes in UK and US samples. J MED ETHICS vol. 37, (11) 682-687.

Ashcroft RE(2011). Personal financial incentives in health promotion: where do they fit in an ethic of autonomy?. Health Expect vol. 14, (2) 191-200.

Ashcroft RE(2011). The Ethics of Autism: Among Them, But Not of Them. AUTISM vol. 15, (1) 134-136.

Ashcroft R(2011). The Promise of Happiness. TEXTUAL PRACT vol. 25, (2) 369-372.

Priebe S, Bogic M, Ashcroft R, Franciskovic T, Galeazzi GM, Kucukalic A, Lecic-Tosevski D, Morina N et al.(2010). Experience of human rights violations and subsequent mental disorders - a study following the war in the Balkans. Soc Sci Med vol. 71, (12) 2170-2177.

Mein G, Seale C, Tinker A, Bhamra S, Ashcroft R(2010). Does altruism and reciprocity play a part in participation in longitudinal health research studies? Findings from the British Whitehall II study Gill Mein. EUR J PUBLIC HEALTH vol. 20, 167-168.

Priebe S, Sinclair J, Burton A, Marougka S, Larsen J, Firn M, Ashcroft R(2010). Acceptability of offering financial incentives to achieve medication adherence in patients with severe mental illness: a focus group study. J Med Ethics vol. 36, (8) 463-468.

Ashcroft RE(2010). The Ethics and Governance of Human Genetic Databases: European Perspectives. EUR LAW J vol. 16, (2) 245-247.

Ashcroft RE(2010). The Philosophy of Public Health. J PUBLIC HEALTH-UK vol. 32, (1) 141-141.

ASHCROFT RE(2010). Could Human Rights Supersede Bioethics?. Human Rights Law Review vol. 10, (4) 639-660.

Ashcroft R(2009). Medical ethics and the healthcare rights of citizens and others. BRIT J GEN PRACT vol. 59, (567) 720-721.

Priebe S, Burton A, Ashby D, Ashcroft R, Burns T, David A, Eldridge S, Firn M et al.(2009). Financial incentives to improve adherence to anti-psychotic maintenance medication in non-adherent patients - a cluster randomised controlled trial (FIAT). BMC Psychiatry vol. 9,

Gilmore A, Britton J, Arnott D, Ashcroft R, Jarvis M(2009). The potential role of snus products within a tobacco harm reduction strategy. J PUBLIC HEALTH-UK vol. 31, (2) 311-311.

Marteau TM, Ashcroft RE, Oliver A(2009). Using financial incentives to achieve healthy behaviour. BRIT MED J vol. 338, Article b1415,

Djulbegovic B, Guyatt GH, Ashcroft RE(2009). Epistemologic Inquiries in Evidence-Based Medicine. CANCER CONTROL vol. 16, (2) 158-168.

O'Reilly M, Dixon-Woods M, Angell E, Ashcroft R, Bryman A(2009). Doing accountability: a discourse analysis of research ethics committee letters. Sociol Health Illn vol. 31, (2) 246-261.

Gilmore AB, Britton J, Arnott D, Ashcroft R, Jarvis MJ(2009). The place for harm reduction and product regulation in UK tobacco control policy. J PUBLIC HEALTH-UK vol. 31, (1) 3-10.

Oliver A, Marteau TM, Ashcroft RE(2009). Can financial carrots improve health?. J HEALTH SERV RES PO vol. 14, (1) 1-2.

Ballantyne A, Newson AJ, Luna F, Ashcroft R(2009). Prenatal Diagnosis and Abortion for Congenital Abnormalities: Is It Ethical to Provide One Without the Other?. AM J BIOETHICS vol. 9, (8) 48-56.

Ballantyne A, Newson AJ, Luna F, Ashcroft R(2009). Response to Open Peer Commentaries on "Prenatal Diagnosis and Abortion for Congenital Abnormalities: Is It Ethical to Provide One Without the Other?". AM J BIOETHICS vol. 9, (8) W6-W7.

Ashcroft R(2009). The Psychology of Repugnance and the Duty to Trust. AM J BIOETHICS vol. 9, (10) 51-52.

Marteau TM, Oliver A, Ashcroft RE(2008). Changing behaviour through state intervention. BRIT MED J vol. 337, Article a2543,

Dixon-Woods M, Ashcroft RE(2008). Regulation and the social licence for medical research. Med Health Care Philos vol. 11, (4) 381-391.

van Delden JJM, Ashcroft R, Dawson A, Marckmann G, Upshur R, Verweij MF(2008). The ethics of mandatory vaccination against influenza for health care workers. VACCINE vol. 26, (44) 5562-5566.

Ashcroft RE, Marteau TM, Oliver A(2008). Payment to look after health - Incentive mechanisms require deeper understanding. BRIT MED J vol. 337, (7665) Article a1135,

Smart A, Tutton R, Martin P, Ellison GTH, Ashcroft R(2008). The standardization of race and ethnicity in biomedical science editorials and UK biobanks. SOC STUD SCI vol. 38, (3) 407-423.

Street JM, Braunack-Mayer AJ, Facey K, Ashcroft RE, Hiller JE(2008). Virtual community consultation? Using the literature and weblogs to link community perspectives and health technology assessment. HEALTH EXPECT vol. 11, (2) 189-200.

Millar M, Coast J, Ashcroft R(2008). Are meticillin-resistant Staphylococcus aureus bloodstream infection targets fair to those with other types of healthcare-associated infection or cost-effective?. J HOSP INFECT vol. 69, (1) 1-5.

Angell EL, Bryman A, Ashcroft RE, Dixon-Woods M(2008). An analysis of decision letters by research ethics committees: the ethics/scientific quality boundary examined. Qual Saf Health Care vol. 17, (2) 131-136.

Ashcroft R(2008). Fair Process and the Redundancy of Bioethics: A Polemic. PUBLIC HEALTH ETHICS vol. 1, (1) 3-9.

Ashcroft RE(2008). Regulating biomedical enhancements in the military. Am J Bioeth vol. 8, (2) 47-49.

Tutton R, Smart A, Martin PA, Ashcroft R, Ellison GTH(2008). Genotyping the future: scientists' expectations about race/ ethnicity after BiDil. J Law Med Ethics vol. 36, (3) 464-470.

ASHCROFT RE(2008). The Troubled Relationship between Bioethics and Human Rights. Law and Bioethics: Current Legal Issues Volume 11, vol. 11, Oxford University Press (Oxford),

ASHCROFT RE(2008). The troubled relationship between Bioethics and Human Rights. Law and Bioethics vol. 11, (22) 31-52.

Dixon-Woods M, Ashcroft RE, Jackson CJ, Tobin MD, Kivits J, Burton PR, Samani NJ(2007). Beyond "misunderstanding": Written information and decisions about taking part in a genetic epidemiology study. SOC SCI MED vol. 65, (11) 2212-2222.

Ellison GTH, Smart A, Tutton R, Outram SM, Ashcroft R, Martin P(2007). Racial categories in medicine: a failure of evidence-based practice?. PLoS Med vol. 4, (9)

Dixon-Woods M, Angell E, Ashcroft RE, Bryman A(2007). Written work: The social functions of Research Ethics Committee letters. SOC SCI MED vol. 65, (4) 792-802.

Holm S, Ashcroft R(2007). Should genetic information be disclosed to insurers?. BRIT MED J vol. 334, (7605) 1196-1197.

Ashcroft RE(2007). Human rights and ethics in genomic research: rethinking the model. Pharmacogenomics vol. 8, (4) 391-395.

Hodgson S, Sharifi R, Richardson G, Ashcroft R, Aziz A, Jackson S, Farrell M, Raza T et al.(2007). Emerging concerns abour Iran's scientific and medical future. CLIN MED vol. 7, (1) 92-93.

Ashcroft RE(2007). Scientific or social priorities for brain science?--making a difference. Nutr Health vol. 19, (1-2) 135-137.

Renshaw A, Clarke A, Diver AJ, Ashcroft RE, Butler PEM(2006). Informed consent for facial transplantation. TRANSPLANT INT vol. 19, (11) 861-867.

Aceijas C, Oppenheimer E, Stimson GV, Ashcroft RE, Matic S, Hickman M, Ref Grp HIV AIDS Prevention, Care IDU Developing Transitional C(2006). Antiretroviral treatment for injecting drug users in developing and transitional countries 1 year before the end of the 'Treating 3 million by 2005. Making it happen. The WHO strategy' ('3by5'). ADDICTION vol. 101, (9) 1246-1253.

Ashcroft RE(2006). Fair rationing is essentially local: an argument for postcode prescribing. Health Care Anal vol. 14, (3) 135-144.

Ashcroft RE, Hedgecoe AM(2006). Genetic databases and pharmacogenetics: introduction. Stud Hist Philos Biol Biomed Sci vol. 37, (3) 499-502.

ASHCROFT R, Sheikh A, Car J, Freeman GK(2006). Interventions for Improving Patients' Trust in Doctors and Groups of Doctors. Cochrane Database of Systematic Reviews vol. 2006, (3) CD004134-CD004134.

Ashcroft RE(2006). Getting what you pay for? The ethics of selective publication. INT J DRUG POLICY vol. 17, (3) 238-239.

Rhodes M, Ashcroft R, Atun RA, Freeman GK, Jamrozik K(2006). Teaching evidence-based medicine to undergraduate medical students: a course integrating ethics, audit, management and clinical epidemiology. Med Teach vol. 28, (4) 313-317.

ASHCROFT R, Tutton R, Smart A, Ellison GTH, Martin PA(2006). Can Science Alone Improve the Measurement and Communication of Race and Ethnicity in Genetic Research? Exploring the Strategies Proposed by Nature Genetics. Biosocieties vol. 1, (3) 313-324.

ASHCROFT R(2006). Individual freedom versus collective responsibility: An ethicist’s perspective. Emerging Themes in Epidemiology vol. 3, Article 11, 11-11.

Ashcroft RE(2006). The politics of personalised medicine: Pharmacogenetics in the clinic. AGEING SOC vol. 26, 154-156.

Ashcroft RE(2005). Making sense of dignity. J Med Ethics vol. 31, (11) 679-682.

Ashcroft RE, Newson AJ, Benn PMW(2005). Reforming research ethics committees - Latest proposals are a missed opportunity for a radical review. BRIT MED J vol. 331, (7517) 587-588.

Ashcroft RE(2005). Ethics committees and countries in transition: a figleaf for structural violence?. BMJ vol. 331, (7510) 229-230.

ASHCROFT R(2005). After the trial is over: What are the sponsor’s obligations. SciDev.Net

Ashcroft RE(2005). Access to essential medicines: a Hobbesian social contract approach. Dev World Bioeth vol. 5, (2) 121-141.

Ashcroft RE(2005). Standing up for the medical rights of asylum seekers. J MED ETHICS vol. 31, (3) 125-126.

Ashcroft RE(2005). Quality of Life as the Basis of Health Care Resource Allocation: A Philosopher's Perspective on QALYs. Virtual Mentor vol. 7, (2)

ASHCROFT R, Schüklenk U(2005). Affordable access to essential medication in developing countries: Conflicts between ethical and economic imperatives. Ethics & AIDS in Africa: The Challenge to Our Thinking Claremont, Editors: Von, NAA, Kopelman, LM, David Phillip (South Africa),

ASHCROFT R(2005). Bioethics in a Small World. Editors: Thiele, F, Ashcroft, R, Springer (Berlin),

ASHCROFT R(2005). Case Analysis in Clinical Ethics. Editors: Ashcroft, R, Verkerk, M, Parker, MJ, Widdershoven, G et al., Cambridge University Press (Cambridge),

ASHCROFT R, Kent J, Goodenough T, Williamson E(2005). Conducting research with children: The limits of confidentiality and child protection protocols. Children and Society vol. 19, 397-409.

ASHCROFT R(2005). Death Policy in the United Kingdom. End-of-Life Decision Making: A Cross-National Study, Editors: Blank, RH, Merrick, JC, MIT press (MA),

Ashcroft RE, Gui KP(2005). Ethics and world pictures in Kamm on enhancement. Am J Bioeth vol. 5, (3) 19-20.

ASHCROFT R(2005). La politica della procreazione assistita in Italia: uno sguardo dal Regno Unito” (“The Politics of Assisted Reproduction in Italy: A perspective from the United Kingdom. Bioetica vol. 3, 91-98.

ASHCROFT R(2005). Legislating to prevent exposure to environmental tobacco smoke in public places and workplaces: ethical and civil liberties arguments. Tobacco Advisory Group of the Royal College of Physicians Going Smoke-Free: The Medical Case for Clean Air in the Home, at Work and in Public Places, Royal College of Physicians (London),

ASHCROFT R, Verkerk M, Parker MJ, Widdershoven G(2005). Philosophical Introduction: Case Analysis in Clinical Ethics. Case Analysis in Clinical Ethics, Editors: Ashcroft, RE, Parker, MJ, Widdershoven, G, Verkerk, M et al., Cambridge University Press (Cambridge),

ASHCROFT R, Widdershoven G, Parker MJ, Verkerk M(2005). Philosophical Reflections. Case Analysis in Clinical Ethics, Editors: Ashcroft, RE, Parker, MJ, Widdershoven, G, Verkerk, M et al., Cambridge University Press (Cambridge),

ASHCROFT R(2005). Unlooked For Discoveries. Hybrids: Towards a New Typology of Beings and Animal, Editors: RE, CEWA, The authors (London),

ASHCROFT R, Majeed FA(2005). Using children of asylum seekers and refugees as translators can create psychological problems for both parents and children. NWLJGP North West London Journal of General Practice vol. 11, (1)

Newson AJ, Ashcroft RE(2005). Whither authenticity?. Am J Bioeth vol. 5, (3) 53-55.

ASHCROFT R(2005). ’Power, Corruption and Lies’: Ethics and Power. Case Analysis in Clinical Ethics, Editors: Ashcroft, RE, Parker, MJ, Widdershoven, G, Verkerk, M et al., Cambridge University Press (Cambridge),

Ashcroft RE(2004). Gene therapy in the clinic: whose risks?. Trends Biotechnol vol. 22, (11) 560-563.

Edwards SJL, Ashcroft R, Kirchin S(2004). Research ethics committees: Differences and moral judgement. BIOETHICS vol. 18, (5) 408-427.

Ashcroft RE(2004). Balancing benefits and harms in health care - Ethical dimension was not discussed in theme issue. BRIT MED J vol. 329, (7463) 458-458.

Ashcroft RE(2004). Drugs symposium: introduction. J MED ETHICS vol. 30, (4) 332-332.

Cook A, Ashcroft R, Sheikh A(2004). Effectiveness of cycle helmets and the ethics of legislation - Author's reply. J ROY SOC MED vol. 97, (8) 410-411.

Ashcroft RE, Franey C(2004). Further ethical and social issues in using a cocaine vaccine: response to Hall and Carter. J Med Ethics vol. 30, (4) 341-343.

Parker M, Ashcroft R, Wilkie AOM, Kent A(2004). Ethical review of research into rare genetic disorders. BRIT MED J vol. 329, (7460) 288-289.

Sheikh A, Cook A, Ashcroft R(2004). Making cycle helmets compulsory: ethical arguments for legislation. J ROY SOC MED vol. 97, (6) 262-265.

Ashcroft RE(2004). Current epistemological problems in evidence based medicine. J Med Ethics vol. 30, (2) 131-135.

Ashcroft R, ter Meulen R(2004). Ethics, philosophy, and evidence based medicine. J MED ETHICS vol. 30, (2) 119-119.

ASHCROFT R(2004). Bioethics. Gynecologic Cancer; Controversies in Management, Editors: al, GDE, Elsevier Churchill Livingstone (Philadelphia),

ASHCROFT R(2004). Bioethics and Conflicts of Interest. Studies in History and Philosophy of Biological and Biomedical Sciences vol. 35, 155-165.

ASHCROFT R(2004). Children’s participation in genetic epidemiology: consent and control. Genetic Databases: Socio-ethical issues in the collection and use of DNA, Editors: Tutton, R, Corrigan, O, Routledge (London),

ASHCROFT R(2004). Ethical protection in research: Including children in the debate. Researchers and their ‘Subjects’, Editors: Williamson, E, Policy press (Bristol),

Ashcroft RE(2004). Ethics of randomised controlled trials--not yet time to give up on equipoise. Arthritis Res Ther vol. 6, (6) 237-239.

Butler PEM, Clarke A, Ashcroft RE(2004). Face transplantation: When and for whom?. AM J BIOETHICS vol. 4, (3) 16-17.

ASHCROFT R(2004). Foreword. Medical Ethics and Law: An introduction, Editors: Tippett, V, Radcliffe Medical Press (Oxford),

Ashcroft RE(2004). From public interest to political justice. Camb Q Healthc Ethics vol. 13, (1) 20-27.

ASHCROFT R, Hettiaratchy S, Thornburn G, Butler PEM(2004). Patient selection for facial transplantation III: Ethical considerations. Int J Surgery vol. 2, 118-119.

ASHCROFT R, Goodenough T, Kent J, Williamson E(2004). Social Science Gets the Ethics Treatment: Research Governance and Ethical Review. Sociological Research Online vol. 7, (4)

Ashcroft RE(2003). The ethics and governance of medical research: what does regulation have to do with morality?. New Rev Bioeth vol. 1, (1) 41-58.

Ashcroft RE(2003). In vitro fertilisation for all? The question is for local purchasers to answer, not for NICE. BRIT MED J vol. 327, (7414) 511-512.

Levine AM, Hancock BW, MacPhail P, Ruff P, Ashcroft RE(2003). The treatment of AIDS-related cancers. LANCET ONCOL vol. 4, (9) 576-581.

Ashcroft R(2003). Bach to the future: response to: Extending preimplantation genetic diagnosis: medical and non-medical uses. J Med Ethics vol. 29, (4) 217-219.

Ashcroft R(2003). Ethical issues in biomedical publications. BIOETHICS vol. 17, (4) 371-374.

Hickman M, Carnwath Z, Madden P, Farrell M, Rooney C, Ashcroft R, Judd A, Stimson G(2003). Drug-related mortality and fatal overdose risk: pilot cohort study of heroin users recruited from specialist drug treatment sites in London. J Urban Health vol. 80, (2) 274-287.

Ashcroft RE(2003). Kant, Mill, Durkheim? Trust and autonomy in bioethics and politics. Stud Hist Philos Biol Biomed Sci vol. 34, (2) 359-366.

Ashcroft RE(2003). The double helix 50 years on: models, metaphors, and reductionism. J MED ETHICS vol. 29, (2) 63-64.

Hurwitz B, Cook A, Ashcroft R(2003). Erectile dysfunction: NHS should meet current need before preventing future medical needs. BRIT MED J vol. 326, (7389) 598-598.

Ashcroft RE(2003). Constructing empirical bioethics: Foucauldian reflections on the empirical turn in bioethics research. Health Care Anal vol. 11, (1) 3-13.

Ashcroft R(2003). Euthanasia, regulation and slippery slopes. Palliat Med vol. 17, (2) 222-224.

Ashcroft RE(2003). American biofutures: ideology and utopia in the Fukuyama/Stock debate. J Med Ethics vol. 29, (1) 59-62.

Ashcroft R, Goodenough T, Williamson E, Kent J(2003). Children's consent to research participation: social context and personal experience invalidate fixed cutoff rules. Am J Bioeth vol. 3, (4) 16-18.

ASHCROFT R(2003). Consent, inducement and conflict of interest in medical research and development. Issues in Medical Research Ethics: A Workbook for Practitioners and Students, Editors: Boomgaarden, J, Louhiala, P, Wiesing, U, Berghahn Books (Oxford),

ASHCROFT R(2003). Equity and compassion. Lancet Oncology vol. 4, 579-581.

ASHCROFT R(2003). On Not Wanting to be Injured and Insulted: Counterpoint to Wolbring. Disability Policy Studies vol. 14, (3) 181-184.

ASHCROFT R(2003). The Ethical Review of Student Projects. Manual for Research Ethics Committees, Editors: Eckstein, S, Cambridge University Press (Cambridge),

ASHCROFT R(2003). The case of challenging behaviour. Issues in Medical Research Ethics: A Workbook for Practitioners and Students, Editors: Boomgaarden, J, Louhiala, P, Wiesing, U, Berghahn Books (Oxford),

ASHCROFT R(2003). Trust and autonomy in bioethics and politics. Studies in History and Philosophy of Biological and Biomedical Sciences vol. 34, 359-366.

ASHCROFT R, Williamson E, Kent J, Goodenough T(2003). What did you think about that? Researching children’s perceptions of participation in a longitudinal genetic epidemiological study. Children and Society vol. 17, 113-125.

Swift TL, Ashcroft RE, Tadd W, Campbell AV, Dieppe PA(2002). Living well through chronic illness: The relevance of virtue theory to patients with chronic osteoarthritis. ARTHRIT RHEUM-ARTHR vol. 47, (5) 474-478.

Sheikh A, Smeeth L, Ashcroft R(2002). Randomised controlled trials in primary care: scope and application. Br J Gen Pract vol. 52, (482) 746-751.

Ashcroft R(2002). Ethics and pluralism. NEW SCI vol. 175, (2355) 27-27.

ASHCROFT R(2002). What is clinical effectiveness. Studies in the History and Philosophy of the Biological and Biomedical Sciences vol. 33, (2) 219-233.

Ashcroft R(2002). Commentary: biomedical research, trade policy and international health: beyond medical ethics. Soc Sci Med vol. 54, (7) 1143-1144.

Schuklenk U, Ashcroft RE(2002). Affordable access to essential medication in developing countries: Conflicts between ethical and economic imperatives. J MED PHILOS vol. 27, (2) 179-195.

ASHCROFT R(2002). An ethical perspective: Nursing research. Nursing Law and Ethics, Editors: Tingle, J, Cribb, A, Blackwell (Oxford),

ASHCROFT R(2002). Essay review of WHO “Genomics and World Health” and Gregory Stock “Redesigning Humans. Bulletin of the World Health Organisation vol. 80, 985-986.

ASHCROFT R(2002). Ethical Issues in Outsourced Clinical Trials. Outsourcing in Clinical Drug Development Englewood, Editors: Drucker, R, Hughes, G, Interpharm Press

ASHCROFT R(2002). Made to measure treatments?. Biological Sciences Review vol. 14, 34-36.

Ashcroft R, Fraser B, Kerr M, Ahmed Z(2001). Are antipsychotic drugs the right treatment for challenging behaviour in learning disability?: The place of a randomised trial. J Med Ethics vol. 27, (5) 338-343.

Ashcroft R(2001). Responsibilities of sponsors are limited in premature discontinuation of trials. BMJ vol. 323, (7303)

Ashcroft R, Pfeffer N(2001). Ethics behind closed doors: do research ethics committees need secrecy?. BMJ vol. 322, (7297) 1294-1296.

Slowther A, Hope T, Ashcroft R(2001). Clinical ethics committees: a worldwide development. J MED ETHICS vol. 27, I1-I1.

Ashcroft RE(2001). Ethics in medical research: A handbook of good practice. J MED ETHICS vol. 27, (2) 140-140.

Swift TL, Ashcroft RE, Dieppe PA, Tadd W(2001). The virtuous patient: what personal qualities do arthritis patients think they should possess?. RHEUMATOLOGY vol. 40, 27-27.

Ashcroft RE(2001). Emphasis has shifted from medical ethics to bioethics. BRIT MED J vol. 322, (7281) 302-303.

ASHCROFT R(2001). Autonomy and informed consent in the ethics of the randomized controlled trial: philosophical perspectives. The Cambridge Medical Ethics Workbook, Editors: Parker, MJ, Dickenson, D, Cambridge University Press (Cambridge),

ASHCROFT R(2001). Ethical aspects in experiments. International Encyclopedia of Social and Behavioural Sciences, Editors: Smelser, NJ, Baltes, PB, Pergamon (Oxford),

ASHCROFT R(2001). Ethics of Clinical Trials: Social, Cultural and Economic Factors. The Advanced Handbook of Methods in Evidence Based Health Care London, Editors: Stevens, A, Abrams, K, Brazier, J, Fitzpatrick, R et al., SAGE

ASHCROFT R(2001). Medical Ethics. A Reader’s Guide to the History of Science, Editors: Hessenbruch, A, Fitzroy Dearborn (London),

Ashcroft RE(2001). Money, consent, and exploitation in research. Am J Bioeth vol. 1, (2) 62-63.

ASHCROFT R, Fraser W, Kerr M, Ahmed Z(2001). The ethics of evidence-based medicine: A randomised controlled trial of antipsychotic drugs for challenging behaviour in learning disability. Journal Medical Ethics vol. 27, 338-343.

Ashcroft R(2001). The family: organic and mechanistic solidarity. Am J Bioeth vol. 1, (3) 22-23.

ASHCROFT R, Parker M, Hope RA(2001). Theoretical Perspectives on Evidence-Based Patient Choice. Evidence-Based Patient Choice, Editors: Edwards, A, Elwyn, G, Oxford University Press (Oxford),

Ashcroft RE(2000). Look at it this way - Agriculture, ethics and biotechnology: spiritual values or scientific good sense?. OUTLOOK AGR vol. 29, (4) 232-234.

Street K, Ashcroft R, Henderson J, Campbell AV(2000). The decision making process regarding the withdrawal or withholding of potential life-saving treatments in a children's hospital. J Med Ethics vol. 26, (5) 346-352.

Ashcroft R(2000). Giving medicine a fair trial. Trials should not second guess what patients want. BMJ vol. 320, (7251)

Ashcroft R(1999). Equipoise, knowledge and ethics in clinical research and practice. Bioethics vol. 13, (3-4) 314-326.

Ashcroft R(1999). To feed or not to feed? Ethical issues in nutritional support. Bull Med Ethics vol. No. 148, 17-18.

Ashcroft R, Toth B(1997). Informed consent. Research suffers if patients suspect that their rights may be breached. BMJ vol. 315, (7102)